Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 01164)
ANNOUNCEMENT
PRICE SENSITIVE INFORMATION AND PROFIT WARNING
This announcement is made pursuant to Rule 13.09 of the Rules
Governing the Listing of
Securities on The Stock Exchange of Hong Kong Limited.
Reference is made to the announcement dated 4 August 2011
(the ''Announcement'') and the 2011
interim report (the ''Interim
Report'') of Vital Group Holdings Limited (the
''Company''). The Company and its subsidiaries are collectively referred as the Group (the
''Group'').
As disclosed in the Announcement, the Group discovers that
since June 2011, there has been a substantial drop in the
sales of Osteoform compound calcium amino acid chelate food
capsule (''Osteoform Food
Product''). The food hygiene licence obtained by
the Group was expired on 25 November 2011. Due to the change
of relevant rules and regulations relating to food hygiene,
the food hygiene licence for Osteoform Food Product was
unable to obtain its renewal.
Further, considering the uncertainties with the renewal of
the import drug licence for Osteoform Compound Calcium Amino
Acid Chelate Capsules, the Group has stopped the production
of Osteoform Food Product. The Group is currently
accelerating the sales of inventory of Osteoform Food
Product. In addition, due to integration of production line
of Vital Pharmaceuticals (Sichuan) Co., Ltd., a wholly-owned
subsidiary of the Company, there was idleness of certain
plants and equipment.
As a result of the above events and after reviewing the
available financial information of the
Group, the Board is of the view that the profits of the Group
for the nine months ended 30
September 2011 are expected to record a substantial decrement
when compared with the corresponding period in 2010, due to
the impairment for goodwill and inventory, impairment loss
for property, plant and equipment of subsidiaries of the
Company as a result of integration of production lines, staff
compensation and the decrease in sales of Osteoform Food
Product.
- 1 -
The Company is in the process of preparing the unaudited
results of the Group for the nine months ended 30 September
2011. The information contained in this announcement is only
based on the preliminary assessment by the
Company's management according to the
preliminary draft consolidated financial statements of the
Group. Details of the Group's performance will
be disclosed as and when the unaudited results for the nine
months ended
30 September 2011 are announced.
Shareholders of the Company and potential investors are
advised to exercise caution when dealing in shares of the
Company.
By Order of the Board Vital Group Holdings Limited Mr. He
Zuyuan
Chief Executive Officer
Hong Kong, 8 December 2011
As at the date of this announcement, the board of directors
of the Company comprises two executive directors: Mr. He
Zuyuan (chief executive officer) and Mr. Li Zhengguang, four
non-executive directors: Mr. Yu Zhiping (chairman), Mr. Wei
Qiyan, Ms. Zheng Xiaowei and Mr. Chen Zhiyu and three
independent non-executive directors: Mr. Ling Bing, Mr. Qiu
Xianhong and Mr. Huang Jinsong.
- 2 -
distribué par | Ce noodl a été diffusé par Vital Group Holdings Ltd. et initialement mise en ligne sur le site http://www.vital-pharm.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2011-12-08 14:59:51 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
Documents associés | |
·ANNOUNCEMENT - PRICE SENSITIVE INFORMATION AND PRO.. |